04/19/2024 3:35 PM | Crombez Eric (Reporting) Ultragenyx Pharmaceutical (Issuer) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/18/2024 5:06 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 7:07 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2024 12:41 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:39 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 11:54 AM | Fust Matthew K (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:13 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/05/2024 7:15 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:17 PM | Huang Dennis Karl (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:19 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:22 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:23 PM | Horn Howard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:06 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:08 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:10 PM | Crombez Eric (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:46 AM | RTW INVESTMENTS, LP (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
02/13/2024 2:41 PM | SANDS CAPITAL MANAGEMENT, LLC (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G | |
02/08/2024 2:49 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 9:18 AM | Ultragenyx Pharmaceutical (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/29/2024 2:26 PM | BlackRock Inc. (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
01/08/2024 5:03 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:17 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 4:22 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2023 4:14 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2023 3:47 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2023 5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/20/2023 5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
10/19/2023 3:45 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2023 6:49 PM | Ultragenyx Pharmaceutical (Subject)
| Form FWP | |
10/17/2023 3:13 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
10/16/2023 7:05 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2023 11:48 AM | Horn Howard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/10/2023 11:50 AM | Horn Howard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 1:15 PM | Crombez Eric (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 1:16 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 12:33 PM | Ultragenyx Pharmaceutical (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
09/11/2023 12:52 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 7:00 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 4:01 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 4:50 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 4:51 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
09/05/2023 5:43 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2023 7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/06/2023 7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2023 3:23 PM | Sanders Corazon D. (0001796536) (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023 1:34 PM | Sanders Corazon D. (0001796536) (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 5:17 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2023 12:00 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/09/2023 1:28 PM | Ultragenyx Pharmaceutical (Issuer) WELCH DANIEL G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 1:29 PM | Dunsire Deborah (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 1:30 PM | NARACHI MICHAEL (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 1:30 PM | SULIMAN SHEHNAAZ (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 1:31 PM | Sanders Corazon D. (0001796536) (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 1:32 PM | Fust Matthew K (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 1:33 PM | Ray Amrit (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 3:33 PM | Ultragenyx Pharmaceutical (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/19/2023 12:54 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 3:38 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2023 7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2023 7:09 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2023 1:16 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 6:05 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023 3:09 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |